AzurRx BioPharma, Inc.
AZRX · NASDAQ
12/31/2024 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18,059 | -$32,671 | -$15,178 | -$13,534 |
| Dep. & Amort. | $49 | $38 | $1,020 | $798 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $632 | $0 | $0 | $0 |
| Change in WC | $0 | $870 | -$2,682 | $2,331 |
| Other Non-Cash | $8,161 | $32,671 | $2,232 | -$1,907 |
| Operating Cash Flow | -$9,218 | -$11,222 | -$14,034 | -$10,869 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$4 | -$24 | -$55 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $88 | $92 | $0 | -$250 |
| Investing Cash Flow | $88 | $87 | -$24 | -$305 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,542 | $988 | $9,477 | $0 |
| Stock Repurch. | $0 | $16,310 | $0 | $0 |
| Dividends Paid | -$241 | $0 | $0 | $0 |
| Other Fin. Act. | $5,822 | $17,046 | $13,145 | $11,712 |
| Financing Cash Flow | $5,581 | $17,046 | $13,145 | $11,712 |
| Forex Effect | $0 | -$26 | -$26 | $4 |
| Net Chg. in Cash | -$3,548 | $5,886 | -$939 | $541 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,733 | $176 | $1,114 | $573 |
| End Cash | $185 | $6,062 | $176 | $1,114 |
| Free Cash Flow | -$9,218 | -$11,226 | -$14,058 | -$10,925 |